What Are Amgen Investors Betting On?
What Are Amgen Investors Betting On? Trefis
Covered in this story
What has happened since
- Amgen is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Amgen
- Oppenheimer: $439 → $480 by Oct 2027 · Outperform via Investing.com India
- Cantor Fitzgerald: $432 → $440 by Oct 2027 · neutral via MarketBeat
- Scotiabank: $432 → $500 by Oct 2027 · outperform via MarketBeat
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AMGN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Amgen →Dalsna Finance is currently tracking 49 stories mentioning Amgen, the earliest published 2 Jul 2026.
Summary aggregated from Trefis's public RSS feed. The full reporting belongs to Trefis — please read it on their site.